ADAM17 and cancer: Furthermore, ADAM17 inhibitors, the knocking out of the ADAM17 gene, and CD16aS197P expression all promoted the NK cell effector functions against cancer cells opsonized by antibodies against tumor surface antigens3,5,8,9,16.